drugset / Trial / NCT02229968

Efficacy of Amicar for Children Having Craniofacial Surgery

NCT02229968

Phase 2 Active not recruiting 22 enrolled Children's National Research Institute
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Amicar (ε-aminocaproic acid) is effective in reducing blood loss in children undergoing craniofacial reconstruction surgery. The investigators hypothesize that Amicar will decrease intraoperative blood loss and decrease the need for perioperative blood product administration in children undergoing craniofacial surgery.

Timeline

Start
2014-10
Primary completion
2028-01
Completion
2028-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ε-Aminocaproic Acid Unknown 40 mg/kg Intravenous

Indications